These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 10337921)
1. Polyclonal immunoglobulins for intravenous use do not influence the behaviour of cultured oligodendrocytes. Stangel M; Compston A; Scolding NJ J Neuroimmunol; 1999 May; 96(2):228-33. PubMed ID: 10337921 [TBL] [Abstract][Full Text] [Related]
2. Polyclonal IgM influence oligodendrocyte precursor cells in mixed glial cell cultures: implications for remyelination. Stangel M; Bernard D J Neuroimmunol; 2003 May; 138(1-2):25-30. PubMed ID: 12742649 [TBL] [Abstract][Full Text] [Related]
3. Oligodendroglia are protected from antibody-mediated complement injury by normal immunoglobulins ("IVIg"). Stangel M; Compston A; Scolding NJ J Neuroimmunol; 2000 Mar; 103(2):195-201. PubMed ID: 10696915 [TBL] [Abstract][Full Text] [Related]
4. Fingolimod treatment promotes proliferation and differentiation of oligodendrocyte progenitor cells in mice with experimental autoimmune encephalomyelitis. Zhang J; Zhang ZG; Li Y; Ding X; Shang X; Lu M; Elias SB; Chopp M Neurobiol Dis; 2015 Apr; 76():57-66. PubMed ID: 25680941 [TBL] [Abstract][Full Text] [Related]
5. Diosgenin promotes oligodendrocyte progenitor cell differentiation through estrogen receptor-mediated ERK1/2 activation to accelerate remyelination. Xiao L; Guo D; Hu C; Shen W; Shan L; Li C; Liu X; Yang W; Zhang W; He C Glia; 2012 Jul; 60(7):1037-52. PubMed ID: 22461009 [TBL] [Abstract][Full Text] [Related]
6. Promotion of central nervous system remyelination by induced differentiation of oligodendrocyte precursor cells. Mi S; Miller RH; Tang W; Lee X; Hu B; Wu W; Zhang Y; Shields CB; Zhang Y; Miklasz S; Shea D; Mason J; Franklin RJ; Ji B; Shao Z; Chédotal A; Bernard F; Roulois A; Xu J; Jung V; Pepinsky B Ann Neurol; 2009 Mar; 65(3):304-15. PubMed ID: 19334062 [TBL] [Abstract][Full Text] [Related]
7. Mobilization of progenitors in the subventricular zone to undergo oligodendrogenesis in the Theiler's virus model of multiple sclerosis: implications for remyelination at lesions sites. Mecha M; Feliú A; Carrillo-Salinas FJ; Mestre L; Guaza C Exp Neurol; 2013 Dec; 250():348-52. PubMed ID: 24148569 [TBL] [Abstract][Full Text] [Related]
8. Limited remyelination in Theiler's murine encephalomyelitis due to insufficient oligodendroglial differentiation of nerve/glial antigen 2 (NG2)-positive putative oligodendroglial progenitor cells. Ulrich R; Seeliger F; Kreutzer M; Germann PG; Baumgärtner W Neuropathol Appl Neurobiol; 2008 Dec; 34(6):603-20. PubMed ID: 18466224 [TBL] [Abstract][Full Text] [Related]
9. Promotion of remyelination by immunoglobulins: implications for the treatment of multiple sclerosis. Trebst C; Stangel M Curr Pharm Des; 2006; 12(2):241-9. PubMed ID: 16454740 [TBL] [Abstract][Full Text] [Related]
10. HMG-CoA reductase inhibitor augments survival and differentiation of oligodendrocyte progenitors in animal model of multiple sclerosis. Paintlia AS; Paintlia MK; Khan M; Vollmer T; Singh AK; Singh I FASEB J; 2005 Sep; 19(11):1407-21. PubMed ID: 16126908 [TBL] [Abstract][Full Text] [Related]
12. Thymosin beta4 promotes oligodendrogenesis in the demyelinating central nervous system. Zhang J; Zhang ZG; Li Y; Lu M; Zhang Y; Elias SB; Chopp M Neurobiol Dis; 2016 Apr; 88():85-95. PubMed ID: 26805386 [TBL] [Abstract][Full Text] [Related]
14. CNTF promotes the survival and differentiation of adult spinal cord-derived oligodendrocyte precursor cells in vitro but fails to promote remyelination in vivo. Talbott JF; Cao Q; Bertram J; Nkansah M; Benton RL; Lavik E; Whittemore SR Exp Neurol; 2007 Mar; 204(1):485-9. PubMed ID: 17274982 [TBL] [Abstract][Full Text] [Related]
15. The K Albrecht S; Korr S; Nowack L; Narayanan V; Starost L; Stortz F; Araúzo-Bravo MJ; Meuth SG; Kuhlmann T; Hundehege P Glia; 2019 May; 67(5):870-883. PubMed ID: 30623969 [TBL] [Abstract][Full Text] [Related]
16. Effects of interferon-beta on oligodendroglial cells. Heine S; Ebnet J; Maysami S; Stangel M J Neuroimmunol; 2006 Aug; 177(1-2):173-80. PubMed ID: 16753226 [TBL] [Abstract][Full Text] [Related]
17. Progesterone attenuates astro- and microgliosis and enhances oligodendrocyte differentiation following spinal cord injury. Labombarda F; González S; Lima A; Roig P; Guennoun R; Schumacher M; De Nicola AF Exp Neurol; 2011 Sep; 231(1):135-46. PubMed ID: 21704617 [TBL] [Abstract][Full Text] [Related]
19. Effects of thyroid hormone on embryonic oligodendrocyte precursor cell development in vivo and in vitro. Ahlgren SC; Wallace H; Bishop J; Neophytou C; Raff MC Mol Cell Neurosci; 1997; 9(5-6):420-32. PubMed ID: 9361279 [TBL] [Abstract][Full Text] [Related]
20. Immune-modifying agents do not impair the survival, migration or proliferation of oligodendrocyte progenitors (CG-4) in vitro. Halfpenny CA; Scolding NJ J Neuroimmunol; 2003 Jun; 139(1-2):9-16. PubMed ID: 12799015 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]